Reta ZPHC — 60 mg

Scientific Name: Retatrutide
Manufacturer: Zhengzhou Pharmaceutical (ZPHC)
Form: 5 vials × 12 mg (total 60 mg)
Category: Metabolic/weight‑management research compound
Mechanism: Retatrutide is a dual incretin agonist (GLP‑1 and GIP) that supports rapid weight‑loss, appetite regulation, and glycaemic balance.

⚗️ Storage & Handling

• Refrigerate at 35–40 °F (2–4 °C)

• Stable for 30 days at 25 °C (room temperature) for travel

• Keep solution clear and particle‑free; discard if cloudy or discolored

• For research use only — not approved for human consumption outside supervised protocols
  

  Parameter	Standard Range	Notes
  Total content	60 mg	5 vials × 12 mg
  Administration	Subcutaneous injection	Abdomen, thigh, or upper arm
  Cycle length	12–24 weeks	Depends on study design
  Research focus	Appetite control, weight‑loss, glycaemic balance	Dual incretin agonist
  Timing	fasted (morning)